Physician profile
Sung-Eun Yoo
NPI 1093706103
$21,274.13
in general payments reported to CMS, 2019-2025
80 companies · $5,829 in 2025
The $5,829 reported for 2025 was more than what 88% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,529 · 2020: $1,631 · 2021: $2,500 · 2022: $2,299 · 2023: $2,984 · 2024: $3,502 · 2025: $5,829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,896 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,246 · Education: $143 · Long Term Medical Supply Or Device Loan: $29.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,896.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,246.01 |
| Education | $142.65 |
| Long Term Medical Supply Or Device Loan | $29.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $2,549.62 | 2019-2025 | Korlym |
| Novo Nordisk INC | $2,439.29 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $1,409.73 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $1,254.41 | 2019-2025 | Freestyle Libre 3, Eterna, Freestyle Insulinx |
| Radius Health, INC. | $917.27 | 2019-2025 | Tymlos |
| Amgen INC. | $906.69 | 2019-2025 | Evenity, Tepezza, Prolia |
| Medtronic, INC. | $676.28 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Astrazeneca Pharmaceuticals LP | $586.19 | 2019-2023 | Farxiga |
| Insulet Corporation | $583.89 | 2019-2025 | Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $521.01 | 2019-2025 | Jardiance, Synjardy |
| Sanofi-Aventis U.S. LLC | $518.59 | 2019-2025 | |
| Esperion Therapeutics, INC. | $499.26 | 2020-2025 | Nexletol, Nexlizet |
| Xeris Pharmaceuticals, INC. | $489.24 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Senseonics, Incorporated | $447.00 | 2019-2025 | Eversense |
| Dexcom, INC. | $424.60 | 2019-2025 | Dexcom G6 Transmitter |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $385.93 | 2019-2025 | Synthroid |
| Antares Pharma, INC. | $368.78 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Bayer Healthcare Pharmaceuticals INC. | $367.87 | 2021-2025 | |
| Ascendis Pharma Endocrinology INC | $332.98 | 2023-2025 | Yorvipath |
| Mannkind Corporation | $332.87 | 2019-2025 | Afrezza |
| Ibsa Pharma INC. | $316.02 | 2019-2025 | Tirosint, Tirosint, Licart |
| Vivus LLC | $296.17 | 2019-2025 | Qsymia |
| Beta Bionics, INC. | $290.69 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Amarin Pharma, INC. | $283.14 | 2019-2023 | |
| Sequel Med Tech, LLC | $272.81 | 2025 | Twiist |
| Tandem Diabetes Care, INC. | $250.12 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Lifescan, INC. | $242.63 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $229.41 | 2019-2024 | Aveed |
| Amneal Pharmaceuticals LLC | $204.96 | 2021-2025 | Unithroid |
| Merck Sharp & Dohme LLC | $177.52 | 2019-2022 | |
| Zealand Pharma US, INC. | $168.61 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $163.65 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $163.42 | 2019-2025 | Strensiq |
| Nestle Healthcare Nutrition INC. | $116.25 | 2020-2022 | |
| Recordati_rare_diseases_inc. | $104.98 | 2021-2025 | Isturisa, Signifor Lar |
| Currax Pharmaceuticals LLC | $100.34 | 2019-2024 | Contrave |
| Endo USA, INC. | $99.16 | 2024-2025 | Aveed |
| Madrigal Pharmaceuticals | $90.70 | 2025 | Rezdiffra |
| Verity Pharmaceuticals INC. | $85.86 | 2024-2025 | Tlando |
| Valeritas, INC. | $82.54 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.05 | 2020-2021 | |
| Normatec Industries, LP | $75.03 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.60 | 2019 | |
| Kyowa Kirin, INC. | $62.55 | 2023-2025 | Crysvita |
| Medtronic Minimed, INC. | $60.37 | 2019 | |
| Embecta Corp. | $59.47 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Janssen Pharmaceuticals, INC | $59.44 | 2019-2020 | |
| Roche Diabetes Care, INC. | $55.99 | 2019 | |
| Pfizer INC. | $52.50 | 2019-2023 | |
| Tolmar, INC. | $50.91 | 2023-2025 | Jatenzo |
| Companion Medical, INC. | $50.56 | 2020 | |
| Ascensia Diabetes Care US INC. | $50.10 | 2024 | |
| Shire North American Group INC | $50.02 | 2019 | |
| Neurocrine Biosciences, INC. | $49.76 | 2025 | |
| Cequr Corporation | $48.80 | 2024-2025 | Cequr Simplicity |
| Phadia US INC. | $48.68 | 2021-2024 | Immunocap |
| Sandoz INC. | $46.83 | 2025 | Hyrimoz |
| Rhythm Pharmaceuticals, INC. | $45.59 | 2025 | Imcivree |
| Acella Pharmaceuticals, LLC | $42.85 | 2019-2025 | NP Thyroid 60 |
| Intra-Sana Laboratories | $40.57 | 2024 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Eisai INC. | $37.74 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $35.21 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $29.83 | 2019-2023 | Evkeeza |
| Janssen Biotech, INC. | $26.86 | 2019 | |
| Medicure Pharma INC. | $26.01 | 2024 | Zypitamag |
| Nevro Corp. | $24.13 | 2024 | Senza |
| Boston Scientific Corporation | $24.10 | 2022 | |
| Averitas Pharma INC. | $22.98 | 2023 | Qutenza |
| Halozyme INC | $21.70 | 2023 | |
| Inspire Medical Systems, INC. | $21.57 | 2025 | Inspire |
| Aimmune Therapeutics, INC. | $18.78 | 2024 | |
| Azurity Pharmaceuticals, INC. | $18.73 | 2023 | Adthyza |
| Becton, Dickinson and Company | $18.54 | 2021 | |
| Horizon Therapeutics Plc | $17.64 | 2021 | |
| Grt US Holding, INC. | $17.49 | 2022 | |
| Allergan, INC. | $16.68 | 2019 | |
| Almatica Pharma LLC | $14.40 | 2024 | Teriparatide |
| Glaxosmithkline, LLC. | $14.27 | 2025 | Arexvy, Shingrix |
| Acerus Pharmaceuticals Corporation | $12.54 | 2022 | |
| Echosens North America, INC. | $9.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sung-Eun Yoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.